Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Argentina Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20082
20091
20112
20121
20152
20171
20191
20202
20213
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting4
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Eli Lilly and Company3
Novartis Pharmaceuticals3
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
AstraZeneca1
Bayer1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung24
Lung Neoplasms3
Melanoma3
Neoplasm Metastasis3
Carcinoma, Renal Cell2
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma1
Colorectal Neoplasms1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.